ACLX - Arcellx Inc
IEX Last Trade
68.83
1.350 1.961%
Share volume: 327,101
Last Updated: Fri 30 Aug 2024 10:00:00 PM CEST
Research and Development in Biotechnology (except Nanobiotechnology):
0.21%
PREVIOUS CLOSE
CHG
CHG%
$67.48
1.35
2.00%
Fundamental analysis
4%
Profitability
0%
Dept financing
0%
Liquidity
0%
Performance
10%
Performance
5 Days
-0.92%
1 Month
11.46%
3 Months
31.58%
6 Months
2.11%
1 Year
93.52%
2 Year
299.19%
Key data
Stock price
$68.83
DAY RANGE
N/A - N/A
52 WEEK RANGE
$30.88 - $75.10
52 WEEK CHANGE
$0.84
DIVIDEND
N/A
EX-DIVIDEND DATE
N/A
NEXT EARNINGS DATE
11/11/2024
Company detail
CEO: Rami Elghandour
Region: US
Website: https://arcellx.com
Employees: 78
IPO year: -
Issue type: Common Stock
Market: XNAS
Industry: Research and Development in Biotechnology (except Nanobiotechnology)
Sector: Professional, Scientific, and Technical Services
Region: US
Website: https://arcellx.com
Employees: 78
IPO year: -
Issue type: Common Stock
Market: XNAS
Industry: Research and Development in Biotechnology (except Nanobiotechnology)
Sector: Professional, Scientific, and Technical Services
Arcellx Inc. is a clinical-stage biotechnology company. The Company is focused developing controllable cell therapies for the treatment of patients with cancer and other incurable diseases.
Recent news